Personalized immune cell therapy for advanced solid tumors
Treatments studied
Part of Cancer clinical trials.
This trial tests a personalized cell therapy that uses your own immune cells (T-cells) specially modified to target your tumor. It is for people with advanced solid tumors who have run out of standard treatment options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced or metastatic solid tumor cancer that has not responded to standard treatments or has no standard treatment.
- You are between 18 and 70 years old.
- You are generally well enough to do daily activities (ECOG score 0 or 1).
- Doctors must be able to collect a tumor sample to find your unique immune cell markers (TCRs), or you already have that information from a biopsy done within the last year.
- You have adequate organ function (heart, lungs, liver, kidneys, blood counts) and are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an injection of your own immune cells (tumor-infiltrating lymphocytes) to see if they can fight advanced solid tumors like stomach or lung cancer. Doctors will remove one of your tumors, grow the immune cells from it, and then give them back to you.
This trial tests a personalized treatment made from your own immune cells (T-cells) that are modified to attack your tumor. It is for people with advanced solid tumors that have not responded to standard treatments.
This early-stage trial tests KXV01, a personalized cancer treatment made from your own immune cells, for advanced solid tumors that have not responded to standard treatment. The goal is to see if it can help control your cancer and learn about its safety.
This trial tests a new immune cell therapy for people with advanced solid tumors of the lung, liver, colon, rectum, or breast. It aims to see if the treatment is safe and can help shrink or control the cancer.
This study tests a new treatment that uses your own immune cells, called TIL, to fight advanced solid tumors. It may be given alone or with another drug that helps the immune system attack cancer. The goal is to see if this treatment is safe and effective for people who have already tried other treatments.
This study tests a personalized treatment made from your own immune cells (T cells) that are re-engineered to recognize and attack your specific tumor. It is for people with advanced solid tumors that have not responded to other treatments. If you qualify, you will have a blood draw and a tumor sample collected to create your own custom T cell therapy.
Hear when a new Advanced Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.